The Complete
Solution
EVIS EXERA III for
GI Endoscopy
This information is intended for healthcare professionals only and is for informational purposes. To access this information, please confirm you are a healthcare professional.
Yes, I am NO, I am NOT
As this website is intended for healthcare professionals only, we're unfortunately unable to provide access to this information.
olympusaustralia.com.au
I made a selection error.
As the world leader in endoscopy, OLYMPUS provides cutting-edge medical technology to healthcare professionals around the globe. In 1950 we started our commitment to research and development with the first gastrocamera, the precursor of the modern videogastroscope. Our collaborative efforts with the medical community improve both the underlying technologies and the quality of patient care. The experience through approximately 800,000 colonoscopies in Australia and New Zealand per annum using Olympus endoscopes and our focus on clinically proven facts make us the top partner for your endoscopy department.
EVIS EXERA III endoscopy system is setting new standards for technologies focusing on:
The EVIS EXERA III endoscopy system is a leap forward in ease-of-use functionality and state-of-the-art technologies. The result is a system that helps physicians conduct procedures efficiently and helps GI staff members perform setup and reprocessing tasks with ease.
NBI with Dual Focus help to reduce the need to biopsy lesions. NBI improves quality and cost-effectiveness of Barrett’s Oesophagus surveillance.
Source: Clinical trials and meta-analyses
NBI improves lesion detection in the colon. ADR increased by approximately 14% to 48.3% when using NBI compared to white light.
Source: Clinical trials and meta-analyses
ScopeGuide increases the cecal intubation rate. Improves cecal intubation times and patient pain scores.
Source: Clinical trials and meta-analyses
Better cost efficiency while improving quality. Cecal insertion time can be reduced by 20%.
Source: Clinical trials and meta-analyses
Reduce sedation levels and patient pain scores. RIT and ScopeGuide help to decrease the use of sedative drugs while improving patient comfort.
Source: Clinical trials and meta-analyses
Discover more at www.olympus-proven.com.au
Olympus focuses on technologies and solutions that improve endoscopy today. Numerous studies have proven the benefits of EVIS EXERA III. Find out more or download an overview of your clinical and economic benefits.
EVIS EXERA III – itʼs proven.
Economic Benefits of EVIS EXERA III:
Clinical Benefits of EVIS EXERA III:
How it Works
Narrow Band Imaging (NBI) is an optical image enhancement technology. It is made up of filtered light that matches the absorption spectrum of the haemoglobin in the blood, enhancing the contrast and visualisation of vessel patterns in the mucosa, for accurate diagnosis of tissue changes.
How it Works
Dual Focus is a two-stage optical lens technology from Olympus that allows physicians to switch from normal to near focus mode with the push of a button, bringing a new level of visualisation in an easy-to-use package.
The Result
More confidence in optical diagnosis.
Learn More
How it Works
Responsive Insertion Technology (RIT) is a unique combination of three proprietary Olympus technologies that lead to faster and easier navigation:
The Result
Shorter intubation time and less patient discomfort.
Learn More
How it Works
ScopeGuide is an integrated technology for colonoscopy that provides real-time 3D visualisation of scope position and configuration. This new level of visualisation is a helpful tool during colon insertion and provides physicians with the ability to recognise and resolve loops as they form.
The Result
Higher cecal intubation rate and less patient discomfort.
Learn More
Gastroscopes
Colonoscopes
Duodenoscopes
Small Bowel Management
Light Source and Processor
Modular service contracts mean that the service for EVIS EXERA III can be tailored to suit the hospital’s exact requirements.
If you need help or would like to learn more about Olympus products or solutions, get in touch with us. We’re more than happy to accept your inquiry.